safety of glp-1 receptor agonists Mapping the effectiveness and risks GLP-1 Receptor Agonists | New
Description
Mimicking the initial multiple, extensive interactions with the ECD seemed implausible to achieve with smaller, non-peptide molecules
Marso SP, Daniels GH, Brown-Frandsen K, et al
2020;192:E87591
Children 12 or older can take it if they are at or above the 95th weight percentile for their sex and age
Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2022
The paper is one of several in the past year that have documented vision problems in patients using these drugs
